Our aim was to investigate plasma levels of adiponectin, monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in low birth weight (LBW) children and to determine correlations among these adipokines and birth weight and cardiovascular disease risk factors. in a case-control study, the concentrations of adiponectin, MCP-1 and PAI-1 were measured in 180 schoolchildren (ages 6-11 years). MCP-1 and PAI-1 levels were significantly elevated in LBW children. Conversely, adiponectin concentration was significantly reduced in these children. Similar findings were observed after adjustment for current age, gender and abdominal circumference. Because the children with LBW had altered adipokine levels, as well as high...
Objective: Childhood obesity has been associated with metabolic syndrome and cardiovascular diseases...
Background: Several prospective epidemiological studies have demonstrated that high-sensitivity C-re...
Obesity is associated with cardiovascular disease risk factors and metabolic syndrome (MetS). In thi...
Recent findings suggest that low-birth-weight children with current obesity are more likely to have ...
To examine the associations of several markers of adiposity and a wide range of cardiovascular risk ...
International audienceAlthough low levels of plasma adiponectin were associated with an increase in ...
It is known that inflammation accompanies atherosclerotic disease and even the CRP is a predictor of...
Prognostic biomarkers are needed to identify children at increased cardiometabolic risk. The objecti...
OBJECTIVE: Low birthweight is associated with insulin resistance later in life, and adiponectin is k...
Low birthweight (LBW) increases the risk of developing cardiovascular diseases (CVD). Few studies ha...
INTRODUCTION: Pediatric obesity is increasingly prevalent in the Portuguese population. Adipocyte d...
BACKGROUND. Adiponectin (AD) reduces the risk of hypertension because of its anti-inflammatory, anti...
BACKGROUND: Childhood obesity is associated with premature cardiovascular complications. However, li...
Background: The potential mechanism underlying the relationship between the risk of cardiovascular d...
Puberty has been described as a life stage of considerable metabolic risk specially for those with o...
Objective: Childhood obesity has been associated with metabolic syndrome and cardiovascular diseases...
Background: Several prospective epidemiological studies have demonstrated that high-sensitivity C-re...
Obesity is associated with cardiovascular disease risk factors and metabolic syndrome (MetS). In thi...
Recent findings suggest that low-birth-weight children with current obesity are more likely to have ...
To examine the associations of several markers of adiposity and a wide range of cardiovascular risk ...
International audienceAlthough low levels of plasma adiponectin were associated with an increase in ...
It is known that inflammation accompanies atherosclerotic disease and even the CRP is a predictor of...
Prognostic biomarkers are needed to identify children at increased cardiometabolic risk. The objecti...
OBJECTIVE: Low birthweight is associated with insulin resistance later in life, and adiponectin is k...
Low birthweight (LBW) increases the risk of developing cardiovascular diseases (CVD). Few studies ha...
INTRODUCTION: Pediatric obesity is increasingly prevalent in the Portuguese population. Adipocyte d...
BACKGROUND. Adiponectin (AD) reduces the risk of hypertension because of its anti-inflammatory, anti...
BACKGROUND: Childhood obesity is associated with premature cardiovascular complications. However, li...
Background: The potential mechanism underlying the relationship between the risk of cardiovascular d...
Puberty has been described as a life stage of considerable metabolic risk specially for those with o...
Objective: Childhood obesity has been associated with metabolic syndrome and cardiovascular diseases...
Background: Several prospective epidemiological studies have demonstrated that high-sensitivity C-re...
Obesity is associated with cardiovascular disease risk factors and metabolic syndrome (MetS). In thi...